Orthofix Medical Inc.

Orthofix Medical Inc.

OFIXNYSE / NASDAQHealthcareSmall cap

$6.07-$0.27 (-4.3%)

Last close · Data as of Nov 20, 2026

Market cap
$418.0M
P/E
-4.5x
EV / EBITDA
51.8x
Revenue
$822.3M
Net margin
-11.2%
ROCE
-12.1%

-57.5% over the last year

Orthofix Medical Inc. price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
-38.4%
3M
-39.4%
6M
-50.0%
1Y
-57.5%
5Y
-80.5%

52-week range

Day change -$0.27 (-4.3%) from $6 to $6 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in OFIX, bought on each weekday since 2021.

News & filings

What Orthofix Medical filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

ConcernThe company made a net loss of 92.2 million US dollars in fiscal 2025.

Strengths (1)

  • Current assets are 2.45 times current liabilities.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction.

Read moreShow less

Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhance bone fusion; designs, develops, and markets a portfolio of spine fixation implant products for use throughout the spinal column; and offers bone graft substitutes, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers in various forms with supporting graft delivery solutions to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and 7D FLASH Navigation System, a navigation platform for spinal and cranial procedures. The Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market, including deformity correction, limb lengthening, complex fracture management, and limb preservation. This segment also designs, develops, and markets external and internal fixation limb reconstruction products that are coupled with enabling digital technologies to support the entire patient care continuum. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, healthcare providers, ambulatory surgery centers, and out-patient hospitals. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Sector
Healthcare
Shares outstanding
39.8M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$418.0M
P/E
-4.5x
P/B
0.9x
EV / EBITDA
51.8x
EV / Sales
0.6x
P/S
0.5x
52-week high
$16.20
52-week low
$6.07

Profitability

Operating margin
-10.0%
Net margin
-11.2%
EBITDA margin
1.2%
ROE
-20.5%
ROCE
-12.1%
ROIC
-10.6%
ROA
-10.8%
Asset turnover
0.97

Growth

Revenue
$822.3M
Revenue growth, 1Y
2.9%
Revenue CAGR, 3Y
21.3%
Net profit growth, 1Y
-26.8%
Free cash flow
-$1.3M

Solvency

Current ratio
2.45
Debt / Equity
0.40
Debt / Assets
0.21
CFO / Net profit
-0.36
Cash / Market cap
19.6%

Where the revenue went

FY2025 ended in a loss, so the lines are listed rather than drawn as a flow.

LineFY2025
Revenue$822.3M
Cost of revenue$256.3M
Gross profit$566.0M
Operating expenses$648.6M
Research and development$65.8M
Selling, general and administrative$554.3M
Operating income-$82.6M
Interest and other-$8.2M
Pretax income-$90.8M
Tax and other$1.4M
Net income-$92.2M

Revenue and net profit

Revenue grew 2.9% in FY2025; net profit is the dashed line.

Orthofix Medical Inc. revenue and net profit by fiscal year
Orthofix Medical Inc. revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$460.7M-$19.7M
FY2023$746.6M-$151.4M
FY2024$799.5M-$126.0M
FY2025$822.3M-$92.2M

Cash flows

FY2025: $33.3M from operations, -$1.3M free after investment (dashed).

Orthofix Medical Inc. operating and free cash flow by fiscal year
Orthofix Medical Inc. operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022-$11.5M-$34.7M
FY2023-$45.8M-$107.8M
FY2024$25.8M-$9.1M
FY2025$33.3M-$1.3M

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$822.3M+2.9%1Y
EBITDA
$9.9M
Net profit
-$92.2M
Cash from operations
$33.3M+29.3%1Y
Free cash flow
-$1.3M
Revenue CAGR, 3Y
21.3%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$822.3M$9.9M-$92.2M-$1.3M-20.5%+2.9%-26.8%

Monthly returns

Month-by-month returns of OFIX across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$850.6M
Liabilities$400.6M
Equity$450.0M
Paid-in capital$813.8M
Retained earnings-$368.3M

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Healthcare companies placed by value, growth and quality; OFIX highlighted.

P/E against peers

Most of this group is loss-making, so EV / Sales is compared for the companies without a P/E.

EV / Sales, for the companies without earnings

  1. Orthofix Medical Inc. (this company)0.6x

Not shown (no positive earnings and no EV / Sales): Rezolute, Inc., Neurogene Inc.

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
Orthofix Medical Inc.OFIXthis company$418.0M-4.5x0.9x-20.5%51.8x
Emergent BioSolutions Inc.EBS$435.5M8.3x0.8x10.1%3.4x
Evolus, Inc.EOLS$434.6M-8.4x-18.8x223.5%-23.8x
Rezolute, Inc.RZLT$434.3M-5.8x2.7x-45.9%-4.3x
Neurogene Inc.NGNE$434.2M-4.8x1.6x-34.1%-3.9x
ClearPoint Neuro, Inc.CLPT$429.5M-16.8x15.3x-91.1%-21.2x
Cross Country Healthcare, Inc.CCRN$409.0M-4.3x1.3x-29.4%-4.7x
Upstream Bio, Inc.UPB$404.3M-2.8x1.2x-42.2%-1.9x
AirSculpt Technologies, Inc.AIRS$402.8M-34.5x4.6x-13.3%391.4x
Peer median—-5.3x1.5x-31.7%-4.1x

Year-to-date ROI

OFIX since 1 January, against earlier years.

Historical volatility

OFIX's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

Orthofix Medical Inc. operating margin by fiscal year
Orthofix Medical Inc. operating margin by fiscal year
DateOperating margin
FY2022-6.3%
FY2023-19.0%
FY2024-9.7%
FY2025-10.0%
LineFY2025
Cost of revenueCost Of Revenue$256.3M
Gross profitGross Profit$566.0M
Operating expensesOperating Expense$648.6M
Research and developmentResearch And Development$65.8M
Depreciation and amortisationDepreciation And Amortization In Income Statement$28.4M
Depreciation, amortisation and depletionDepreciation Amortization Depletion Income Statement$28.4M
Amortization$28.4M
Amortisation of intangiblesAmortization Of Intangibles Income Statement$28.4M
Total expensesTotal Expenses$904.9M
Pretax incomePretax Income-$90.8M

Learn while you research

Academy chapters picked for Orthofix Medical Inc. and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
  3. 03 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
  4. 04 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  5. 05 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →